Aptus Pharma Ltd.
  • Home
  • Business
    • Range Of Solutions
    • Products
    • Quality Policy
    • Core Management Team
  • Investor Relations
    • DRHP / RHP
      • DRHP
      • RHP
      • Prospectus
    • Announcement
      • Board Meeting
        • Board Meeting Intimation
        • Outcome of the meeting_12.06.26
      • General Meeting
      • Other Announcements
        • Aptus Intimation
        • Intimation of New Product Launch
        • Intimation
        • Lodr 30 Intimation- New Product Shirovita Hair Oil
        • LODR 30 Intimation-enzyking Syrup
        • Intimation_Award Recognition
        • Intimation Bonus
        • Intimation Closure Of Trading Window
        • Postal Ballot Notice
        • Intimation News Paper
        • voting result
        • Board Meeting Intimation
      • Compliances
        • Certificate 74(5)_
        • Certificate under Regulation 74 (5)
        • Financial Result_September
        • Non Applicability of Corporate Governance
        • Reconciliation of Share
        • Reconciliation of Share Capital_September
      • Certificate under_Regulation
    • Material Contracts
    • Investor Grievances
    • Material Documents
    • MOAΒ &Β AOA
      • MOA
      • AOA
    • Financial Reports
      • Annual
        • Annual Return
          • Financial Year 19-20
          • Financial Year 20-21
          • Financial Year 21-22
          • Financial Year 22-23
          • Financial Year 23-24
          • Financial Year 24-25
        • Annual Report
          • Financial Year 2019-20
          • Financial Year 2020-21
          • Financial Year 2021-22
          • Financial Year 2022-23
          • Financial Year 2023-24
          • Financial Year 2024-25
      • Half-yearly /Quarterly
        • 1st Half 25/26
          • Financial Year 25-26 (1st Half)
        • 2nd-half 25/26
          • Outcome of Board Meeting
    • Board of Directors
      • Board Of Directors
      • Profile Of Board Of Directors
      • Committees
    • Shareholder’s Information
      • Share price Information from
        BSE & NSE
      • Intimations
      • Shareholder’s Meet
    • Corporate Governance
      • Policies
      • Terms And Conditions For
        Appointment As Independent
        Director
      • Corporate Announcements
        • Unaudited Financial
          30 Sep 25
        • Board Meeting Intimation
          30Sep 25
        • Clarification On Price
          Movement
        • Clarification sought
      • Newspapers Publication
    • Investor Support
      • Registrar and Transfer Agent
        • Registrar and transfer agent
          to the proposedΒ issue
        • Company registrar and
          transferΒ agent
      • Company Secretary
    • AGM Notice_2024_25
      • Financial Year 24-25
    • Key managerial personnel
  • News & Media
  • Gallery
  • Award & Certification
  • Career
Contact Us
Aptus Pharma Ltd.
  • Home
  • Business
    • Range Of Solutions
    • Products
    • Quality Policy
    • Core Management Team
  • Investor Relations
    • DRHP / RHP
      • DRHP
      • RHP
      • Prospectus
    • Announcement
      • Board Meeting
        • Board Meeting Intimation
        • Outcome of the meeting_12.06.26
      • General Meeting
      • Other Announcements
        • Aptus Intimation
        • Intimation of New Product Launch
        • Intimation
        • Lodr 30 Intimation- New Product Shirovita Hair Oil
        • LODR 30 Intimation-enzyking Syrup
        • Intimation_Award Recognition
        • Intimation Bonus
        • Intimation Closure Of Trading Window
        • Postal Ballot Notice
        • Intimation News Paper
        • voting result
        • Board Meeting Intimation
      • Compliances
        • Certificate 74(5)_
        • Certificate under Regulation 74 (5)
        • Financial Result_September
        • Non Applicability of Corporate Governance
        • Reconciliation of Share
        • Reconciliation of Share Capital_September
      • Certificate under_Regulation
    • Material Contracts
    • Investor Grievances
    • Material Documents
    • MOAΒ &Β AOA
      • MOA
      • AOA
    • Financial Reports
      • Annual
        • Annual Return
          • Financial Year 19-20
          • Financial Year 20-21
          • Financial Year 21-22
          • Financial Year 22-23
          • Financial Year 23-24
          • Financial Year 24-25
        • Annual Report
          • Financial Year 2019-20
          • Financial Year 2020-21
          • Financial Year 2021-22
          • Financial Year 2022-23
          • Financial Year 2023-24
          • Financial Year 2024-25
      • Half-yearly /Quarterly
        • 1st Half 25/26
          • Financial Year 25-26 (1st Half)
        • 2nd-half 25/26
          • Outcome of Board Meeting
    • Board of Directors
      • Board Of Directors
      • Profile Of Board Of Directors
      • Committees
    • Shareholder’s Information
      • Share price Information from
        BSE & NSE
      • Intimations
      • Shareholder’s Meet
    • Corporate Governance
      • Policies
      • Terms And Conditions For
        Appointment As Independent
        Director
      • Corporate Announcements
        • Unaudited Financial
          30 Sep 25
        • Board Meeting Intimation
          30Sep 25
        • Clarification On Price
          Movement
        • Clarification sought
      • Newspapers Publication
    • Investor Support
      • Registrar and Transfer Agent
        • Registrar and transfer agent
          to the proposedΒ issue
        • Company registrar and
          transferΒ agent
      • Company Secretary
    • AGM Notice_2024_25
      • Financial Year 24-25
    • Key managerial personnel
  • News & Media
  • Gallery
  • Award & Certification
  • Career
Aptus Pharma Ltd.

Our Gallery

Contact Info

  • 411 University St, Seattle, USA
  • theratio_interior@mail.com
  • +1 800 456 789 123
Twitter Facebook-f Linkedin-in Instagram

Newspapers Publication

  • Home
  • Newspapers Publication
Newspaper Publication πŸ“‘
Newspaper Publication πŸ“‘
Newspaper Publication πŸ“‘
Newspaper Publication πŸ“‘
Newspaper Publication πŸ“‘
Newspaper Publication πŸ“‘
Newspaper Publication πŸ“‘
Newspaper Publication πŸ“‘
Newspaper Publication πŸ“‘
Newspaper Publication πŸ“‘
Newspaper Publication πŸ“‘
Newspaper Publication πŸ“‘
Newspaper Publication πŸ“‘
Newspaper Publication πŸ“‘
Newspaper Publication πŸ“‘
Newspaper Publication πŸ“‘
Newspaper Publication πŸ“‘
Welcome to Aptus Pharma Ltd., where innovation intersects with compassion on the journey towards global well-being.
Customer Care
  • info@aptuspharma.com
  • +91 76004 27827

Welcome to Aptus Pharma Ltd., where innovation intersects with compassion on the journey towards global well-being.

Facebook-f Instagram
Quick Links
  • Home
  • About Us
  • Our Products
  • Contact Us
Β© Copyright – 2025 Aptus Pharma Ltd.. All Rights Reserved.